Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David McConkey

Showing results (51-60 of 71) with videos related to

Pageof 8
Sort By:
Nature Communications|March 24, 2026
Retraction Note: Re-engineered BCG overexpressing cyclic di-AMP augments trained immunity and exhibits improved efficacy against bladder cancerAlok Kumar Singh, Monali Praharaj, Kara A Lombardo, et al.
The Journal of Pathology|November 3, 2021
BCG invokes superior STING-mediated innate immune response over radiotherapy in a carcinogen murine model of urothelial cancerKara A Lombardo, Aleksandar Obradovic, Alok Kumar Singh, et al.
European Urology Oncology|April 22, 2023
Cell-free DNA Methylation as a Predictive Biomarker of Response to Neoadjuvant Chemotherapy for Patients with Muscle-invasive Bladder Cancer in SWOG S1314Yi-Tsung Lu, Melissa Plets, Gareth Morrison, et al.
Research Square|April 25, 2024
Inferring Bladder Cancer Evolution from Mucosal field Effects by Whole-Organ Spatial Mutational, Proteomic, and Metabolomic MappingBogdan Czerniak, Sangkyou Lee, Sung Yun Jung, et al.
European Urology|March 19, 2016
Gene Expression Profile of the Clinically Aggressive Micropapillary Variant of Bladder CancerCharles Chuanhai Guo, Vipulkumar Dadhania, Li Zhang, et al.
The Journal of Pathology|September 25, 2025
Dysregulated mitochondrial energy metabolism drives the progression of mucosal field effects to invasive bladder cancerSangkyou Lee, Sung Yun Jung, Pawel Kuś, et al.
European Urology|August 21, 2020
Clinical Restaging and Tumor Sequencing are Inaccurate Indicators of Response to Neoadjuvant Chemotherapy for Muscle-invasive Bladder CancerRussell E N Becker, Alexa R Meyer, Aaron Brant, et al.
Cell Reports|April 27, 2024
Loss of LPAR6 and CAB39L dysregulates the basal-to-luminal urothelial differentiation program, contributing to bladder carcinogenesisSangkyou Lee, Jolanta Bondaruk, Yishan Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 19, 2007
Forerunner genes contiguous to RB1 contribute to the development of in situ neoplasiaSangkyou Lee, Joon Jeong, Tadeusz Majewski, et al.
Journal for Immunotherapy of Cancer|October 3, 2025
T cell subsets of urine-derived lymphocytes (UDLs) serve as an indicator of TILs and reflect immunological sex differences in bladder cancerJohanna M Schafer, No-Joon Song, Tong Xiao, et al.
Pageof 8

Showing results (51-60 of 71) with videos related to

Sort By:
Pageof 8
Nature Communications|March 24, 2026
Retraction Note: Re-engineered BCG overexpressing cyclic di-AMP augments trained immunity and exhibits improved efficacy against bladder cancerAlok Kumar Singh, Monali Praharaj, Kara A Lombardo, et al.
The Journal of Pathology|November 3, 2021
BCG invokes superior STING-mediated innate immune response over radiotherapy in a carcinogen murine model of urothelial cancerKara A Lombardo, Aleksandar Obradovic, Alok Kumar Singh, et al.
European Urology Oncology|April 22, 2023
Cell-free DNA Methylation as a Predictive Biomarker of Response to Neoadjuvant Chemotherapy for Patients with Muscle-invasive Bladder Cancer in SWOG S1314Yi-Tsung Lu, Melissa Plets, Gareth Morrison, et al.
Research Square|April 25, 2024
Inferring Bladder Cancer Evolution from Mucosal field Effects by Whole-Organ Spatial Mutational, Proteomic, and Metabolomic MappingBogdan Czerniak, Sangkyou Lee, Sung Yun Jung, et al.
European Urology|March 19, 2016
Gene Expression Profile of the Clinically Aggressive Micropapillary Variant of Bladder CancerCharles Chuanhai Guo, Vipulkumar Dadhania, Li Zhang, et al.
The Journal of Pathology|September 25, 2025
Dysregulated mitochondrial energy metabolism drives the progression of mucosal field effects to invasive bladder cancerSangkyou Lee, Sung Yun Jung, Pawel Kuś, et al.
European Urology|August 21, 2020
Clinical Restaging and Tumor Sequencing are Inaccurate Indicators of Response to Neoadjuvant Chemotherapy for Muscle-invasive Bladder CancerRussell E N Becker, Alexa R Meyer, Aaron Brant, et al.
Cell Reports|April 27, 2024
Loss of LPAR6 and CAB39L dysregulates the basal-to-luminal urothelial differentiation program, contributing to bladder carcinogenesisSangkyou Lee, Jolanta Bondaruk, Yishan Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 19, 2007
Forerunner genes contiguous to RB1 contribute to the development of in situ neoplasiaSangkyou Lee, Joon Jeong, Tadeusz Majewski, et al.
Journal for Immunotherapy of Cancer|October 3, 2025
T cell subsets of urine-derived lymphocytes (UDLs) serve as an indicator of TILs and reflect immunological sex differences in bladder cancerJohanna M Schafer, No-Joon Song, Tong Xiao, et al.
Pageof 8